Non-invasive treatment at Tuen Mun Hospital offers new option, with 40 patients to be treated within two years.

A Finnish clinical imaging study shows that rest tremor in Parkinson's disease is not explained by greater dopamine loss. In ...

Siemens Healthineers announced that its Varian TrueBeam radiotherapy systems, which include TrueBeam, TrueBeam STx, VitalBeam, and Edge, have received FDA 510(k) clearance for the use of low-dose ...

Dr. Rebecca Pratt, a neurologist with Novant Health, was in the studio to talk more about the surgery and how it works.

The Encora X1 is a noninvasive, wrist-worn neurostimulation device designed to reduce hand tremors and improve daily function.

About a decade ago, Joan Riggs, a 64-year-old from Lemoyne, started to have shaky hands. At first, it was an annoyance.

This content is sponsored by The George Washington University Hospital. Rick Desper lived with essential tremors for decades before trying a new treatment recommended by his doctor. Desper said his ...

BOSTON--(BUSINESS WIRE)--Encora Therapeutics, a leader in non-invasive neuromodulation technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...

Millions of people suffer from movement disorders. Praxis Precision Medicines wants to help meet the large unmet need for effective treatment options. Praxis specializes in using genetic insights to ...

Propranolol and Primidone demonstrate efficacy in up to 70% of patients as first-line agents. MR-Guided Focused Ultrasound (MRgFUS) results in approximately 56% tremor reduction at 4 years. Deep Brain ...

(RTTNews) - Praxis Precision Medicines, Inc. (PRAX) on Monday said the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to ulixacaltamide for the treatment of patients ...

The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in essential tremor Praxis remains on track to submit ulixacaltamide NDA in ...